Elevance Health EPS - Earnings per Share 2010-2024 | ELV
Elevance Health annual and quarterly earnings per share history from 2010 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Elevance Health EPS for the quarter ending March 31, 2024 was $9.59, a 15.54% increase year-over-year.
- Elevance Health EPS for the twelve months ending March 31, 2024 was $26.51, a 4.95% increase year-over-year.
- Elevance Health 2023 annual EPS was $25.22, a 3.87% increase from 2022.
- Elevance Health 2022 annual EPS was $24.28, a 2.69% decline from 2021.
- Elevance Health 2021 annual EPS was $24.95, a 38.77% increase from 2020.
| Elevance Health Annual EPS | |
|---|---|
| 2023 | $25.22 |
| 2022 | $24.28 |
| 2021 | $24.95 |
| 2020 | $17.98 |
| 2019 | $18.47 |
| 2018 | $14.19 |
| 2017 | $14.35 |
| 2016 | $9.21 |
| 2015 | $9.38 |
| 2014 | $8.99 |
| 2013 | $8.20 |
| 2012 | $8.18 |
| 2011 | $7.25 |
| 2010 | $6.94 |
| 2009 | $9.88 |
| Elevance Health Quarterly EPS | |
|---|---|
| 2024-03-31 | $9.59 |
| 2023-12-31 | $3.68 |
| 2023-09-30 | $5.45 |
| 2023-06-30 | $7.79 |
| 2023-03-31 | $8.30 |
| 2022-12-31 | $3.61 |
| 2022-09-30 | $6.62 |
| 2022-06-30 | $6.73 |
| 2022-03-31 | $7.32 |
| 2021-12-31 | $4.86 |
| 2021-09-30 | $6.13 |
| 2021-06-30 | $7.25 |
| 2021-03-31 | $6.71 |
| 2020-12-31 | $2.26 |
| 2020-09-30 | $0.87 |
| 2020-06-30 | $8.91 |
| 2020-03-31 | $5.94 |
| 2019-12-31 | $3.65 |
| 2019-09-30 | $4.55 |
| 2019-06-30 | $4.36 |
| 2019-03-31 | $5.91 |
| 2018-12-31 | $1.60 |
| 2018-09-30 | $3.62 |
| 2018-06-30 | $3.98 |
| 2018-03-31 | $4.99 |
| 2017-12-31 | $4.66 |
| 2017-09-30 | $2.80 |
| 2017-06-30 | $3.16 |
| 2017-03-31 | $3.73 |
| 2016-12-31 | $1.37 |
| 2016-09-30 | $2.30 |
| 2016-06-30 | $2.91 |
| 2016-03-31 | $2.63 |
| 2015-12-31 | $0.73 |
| 2015-09-30 | $2.43 |
| 2015-06-30 | $3.13 |
| 2015-03-31 | $3.09 |
| 2014-12-31 | $1.81 |
| 2014-09-30 | $2.22 |
| 2014-06-30 | $2.56 |
| 2014-03-31 | $2.40 |
| 2013-12-31 | $0.51 |
| 2013-09-30 | $2.16 |
| 2013-06-30 | $2.64 |
| 2013-03-31 | $2.89 |
| 2012-12-31 | $1.56 |
| 2012-09-30 | $2.15 |
| 2012-06-30 | $1.94 |
| 2012-03-31 | $2.53 |
| 2011-12-31 | $1.02 |
| 2011-09-30 | $1.90 |
| 2011-06-30 | $1.89 |
| 2011-03-31 | $2.44 |
| 2010-12-31 | $1.43 |
| 2010-09-30 | $1.84 |
| 2010-06-30 | $1.71 |
| 2010-03-31 | $1.96 |
| 2009-12-31 | $5.76 |
| 2009-09-30 | $1.53 |
| 2009-06-30 | $1.43 |
| 2009-03-31 | $1.16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $125.903B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $47.741B | 18.61 |
| ICON (ICLR) | Ireland | $26.139B | 24.68 |
| DiDi Global (DIDIY) | China | $21.386B | 0.00 |
| Avantor (AVTR) | United States | $15.283B | 22.50 |
| CochLear (CHEOY) | Australia | $14.173B | 0.00 |
| Revvity (RVTY) | United States | $13.191B | 23.14 |
| Natera (NTRA) | United States | $13.190B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.644B | 41.60 |
| Viatris (VTRS) | United States | $12.466B | 3.73 |
| Charles River Laboratories (CRL) | United States | $10.809B | 20.69 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.137B | 0.00 |
| Solventum (SOLV) | United States | $8.860B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.681B | 0.00 |
| HealthEquity (HQY) | United States | $7.198B | 46.21 |
| Organon (OGN) | United States | $5.431B | 5.15 |
| Bausch + Lomb (BLCO) | Canada | $5.256B | 21.04 |
| Doximity (DOCS) | United States | $5.107B | 35.77 |
| PACS (PACS) | United States | $4.437B | 0.00 |
| Life Times (LTH) | United States | $3.623B | 37.96 |
| Sotera Health (SHC) | United States | $3.369B | 16.53 |
| Surgery Partners (SGRY) | United States | $3.017B | 27.60 |
| GoodRx Holdings (GDRX) | United States | $2.859B | 108.86 |
| Agilon Health (AGL) | United States | $2.677B | 0.00 |
| Progyny (PGNY) | United States | $2.487B | 42.82 |
| AMN Healthcare Services Inc (AMN) | United States | $2.029B | 8.04 |
| NovoCure (NVCR) | Jersey | $2.014B | 0.00 |
| Premier (PINC) | United States | $1.949B | 8.34 |
| BrightSpring Health Services (BTSG) | United States | $1.852B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.757B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.449B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.226B | 0.00 | |
| CareDx (CDNA) | United States | $0.749B | 0.00 |
| Embecta (EMBC) | United States | $0.722B | 4.91 |
| GeneDx Holdings (WGS) | United States | $0.717B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.695B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.680B | 7.21 |
| Auna S.A (AUNA) | Luxembourg | $0.568B | 0.00 |
| Sharecare (SHCR) | United States | $0.497B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.430B | 0.00 |
| Enhabit (EHAB) | United States | $0.426B | 42.50 |
| ModivCare (MODV) | United States | $0.367B | 6.87 |
| Sonida Senior Living (SNDA) | United States | $0.345B | 0.00 |
| DocGo (DCGO) | United States | $0.310B | 16.94 |
| LifeMD (LFMD) | United States | $0.288B | 0.00 |
| MultiPlan (MPLN) | United States | $0.238B | 0.00 |
| Beauty Health (SKIN) | United States | $0.223B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.212B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.204B | 0.00 |
| Biodesix (BDSX) | United States | $0.189B | 0.00 |
| So-Young (SY) | China | $0.111B | 53.49 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 5.88 |
| Co-Diagnostics (CODX) | United States | $0.043B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.035B | 0.00 |
| Oncology Institute (TOI) | United States | $0.031B | 0.00 |
| Nutex Health (NUTX) | United States | $0.029B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.025B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.023B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| KindlyMD (KDLY) | $0.018B | 0.00 | |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |